Current Advances in Computational Approaches for Drug Discovery- Part II
Gupta, A.K.
Current Topics in Medicinal Chemistry 18(27): 2267
2018
ISSN/ISBN: 1568-0266 PMID: 30767732 Document Number: 695600
Document emailed within 1 workday
Related Documents
Bowen, J.Phillip.; Zhong, H.Andrew. 2015: Advances in Drug Discovery: Many Approaches, One Goal Current Topics in Medicinal Chemistry 2015Khedkar, S.A. 2010: Current computational approaches in medicinal chemistry Current Topics in Medicinal Chemistry 10(1): 1-2
Kubinyi, H. 1998: Combinatorial and computational approaches in structure-based drug design Current Opinion in Drug Discovery and Development 1(1): 16-27
Swart, G.W. 2001: Advances in oncology--drug discovery and apoptosis Idrugs: the Investigational Drugs Journal 4(12): 1337-1338
Prathipati, P.; Mizuguchi, K. 2016: Systems Biology Approaches to a Rational Drug Discovery Paradigm Current Topics in Medicinal Chemistry 16(9): 1009-1025
Ferreira, V.F.; da Rocha, D.R.; Lima Araújo, Kátia.G.; Santos, W.C. 2008: Advances in drug discovery to assess cholinergic neurotransmission: a systematic review Current Drug Discovery Technologies 5(3): 236-249
Zhou, J.; Wild, C. 2019: GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends Current Topics in Medicinal Chemistry 19(16): 1363-1364
Thakur, S.S. 2019: Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - Part-II Current Topics in Medicinal Chemistry 19(17): 1490
Thakur, S.S. 2018: Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - (Part-I) Current Topics in Medicinal Chemistry 18(30): 2543
Feng, W.Yong. 2004: Mass spectrometry in drug discovery: a current review Current Drug Discovery Technologies 1(4): 295-312
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Castillo-González, D.; Pérez-Machado, G.; Pallardó, F.; Garrigues-Pelufo, T-María.; Cabrera-Pérez, M-Angel. 2012: Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity Current Topics in Medicinal Chemistry 12(24): 2843-2856
Favorov, A. 2004: Methodological differences of the physical and computational model approaches Biofizika 49(5): 958-960
Renlund, D.G.; Gerstenblith, G. 1986: Angina: current approaches to diagnosis, drug therapy, and surgical referral Geriatrics 41(1): 35-39; 42 44 Passim
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Cieplak, P. 2000: Some computational aspects of theoretical anti-HIV drug design Acta Poloniae Pharmaceutica 57 Suppl: 33-36
Belitser, V.A. 1977: Oxidative phosphorylation: discovery, early studies, new approaches Molekuliarnaia Biologiia 11(6): 1234-1237
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282